Clinical Trials Directory

Trials / Completed

CompletedNCT06581263

Psychedelic Virtual Reality

Investigating the Use of Virtual Reality in Psychedelic Research or Clinical Practice

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate a novel VRP.

Detailed description

The primary objective of this study is to determine whether the subjective experience of a novel VRP (DeepDream) will be comparable to a standard dose of psychedelics. This study also looks to compare the subjective experience of DeepDream VRP to other available VR modalities developed to mimic psychedelic subjective experience along with assessing the incidence of VRP adverse effects.

Conditions

Interventions

TypeNameDescription
DEVICEMeta Quest 3Meta Quest 3 is a virtual reality headset device

Timeline

Start date
2025-07-22
Primary completion
2026-03-22
Completion
2026-03-22
First posted
2024-09-03
Last updated
2026-03-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06581263. Inclusion in this directory is not an endorsement.

Psychedelic Virtual Reality (NCT06581263) · Clinical Trials Directory